Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes

[1] David TE(2013)Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease Circulation 127 1485-1492

[2] Armstrong S(2012)Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of Valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 42 S1-44

[3] McCrindle BW(2014)2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation 129 e521-e643

[4] Manlhiot C(2017)2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines Circulation 135 e1159-e1195

[5] Vahanian A(2008)Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients Eur J Cardiothorac Surg 34 760-765

[6] Alfieri O(2015)Increasing disadvantage of "watchful waiting" for repairing degenerative mitral valve disease Ann Thorac Surg 99 1992-2000

[7] Andreotti F(2016)Mitral valve disease--current management and future challenges Lancet 387 1324-1334

[8] Antunes MJ(2018)Benefits of early surgery on clinical outcomes after degenerative mitral valve repair Ann Thorac Surg 106 1063-1070

[9] Barón-Esquivias G(2014)Long-term follow-up of asymptomatic or mildly symptomatic patients with severe degenerative mitral regurgitation and preserved left ventricular function J Thorac Cardiovasc Surg 148 2795-2801

[10] Baumgartner H(2015)Etc. is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation J Thorac Cardiovasc Surg 150 50-58

[1] David TE(2013)Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease Circulation 127 1485-1492

[2] Armstrong S(2012)Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of Valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 42 S1-44

[3] McCrindle BW(2014)2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation 129 e521-e643

[4] Manlhiot C(2017)2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines Circulation 135 e1159-e1195

[5] Vahanian A(2008)Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients Eur J Cardiothorac Surg 34 760-765

[6] Alfieri O(2015)Increasing disadvantage of "watchful waiting" for repairing degenerative mitral valve disease Ann Thorac Surg 99 1992-2000

[7] Andreotti F(2016)Mitral valve disease--current management and future challenges Lancet 387 1324-1334

[8] Antunes MJ(2018)Benefits of early surgery on clinical outcomes after degenerative mitral valve repair Ann Thorac Surg 106 1063-1070

[9] Barón-Esquivias G(2014)Long-term follow-up of asymptomatic or mildly symptomatic patients with severe degenerative mitral regurgitation and preserved left ventricular function J Thorac Cardiovasc Surg 148 2795-2801

[10] Baumgartner H(2015)Etc. is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation J Thorac Cardiovasc Surg 150 50-58